Chinese technology giant Alibaba (BABA.US) has been identified as providing technological support for Chinese military “operations” targeting the United States, according to intelligence referenced in a White House national security memo. The memo — shared with the Financial Times — includes newly declassified “top secret” information detailing how the company supplies the People’s Liberation Army with capabilities that Washington views as a threat to U.S. security.
Despite reporting solid earnings, strong revenue performance, and ongoing advances in AI research, Alibaba’s share sell-off continues today as concerns mount over national security implications and the potential for heightened tensions in U.S.–China business relations. Alibaba has not yet commented on the allegations. The stock is down almost 25% since the all-time high in October 2025.
Source: xStation5
US Earnings Season Summary 🗽What the Latest FactSet Data Shows
US Open: US100 initiates rebound attempt 🗽Micron shares near ATH📈
Micron Surges on Record DRAM Pricing
DE40: European markets extend decline
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
